Therabene Inc.
Advancing Degrader-Based Therapeutics for Hard-to-Treat Cancers

Therabene Inc. is a Massachusetts-based biotechnology company pioneering the next generation of targeted protein degradation therapies. Our mission is to develop first-in-class and best-in-class degrader-based medicines to address urgent unmet needs in oncology—specifically triple-negative breast cancer, ovarian cancer, lung cancer, and pancreatic cancer.

Leveraging our deep scientific expertise and collaborative partnerships, we are advancing a pipeline of novel degraders and PROTACs designed to overcome drug resistance and deliver more effective, durable responses for patients. As an early-stage company, we are focused on generating compelling preclinical proof-of-concept data and building strategic relationships to accelerate development.

We are proudly headquartered at Norwood, MA, and committed to innovation, transparency, and impact as we work to bring hope to patients with limited treatment options.

Therabene Inc.

Org chart

Teams

Offices

Therabene Inc.

Org chart

Teams

Offices

Related companies